United States Fibromyalgia Therapeutics Market Report 2016

November 2016 | 96 pages | ID: UC9D396C8FBEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Fibromyalgia Therapeutics

Revenue, means the sales value of Fibromyalgia Therapeutics

This report studies sales (consumption) of Fibromyalgia Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Boehringer Ingelheim GmbH (Germany)
• Chelsea Therapeutics, Inc. (US)
• Claire Ellen Products, Inc. (US)
• Eli Lilly and Company (US)
• Forest Laboratories, Inc. (US)
• Impax Laboratories, Inc. (US)
• Meda AB (Sweden)
• Pfizer, Inc. (US)
• Pierre Fabre Medicament (France)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Fibromyalgia Therapeutics in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Fibromyalgia Therapeutics Market Report 2016

1 FIBROMYALGIA THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Fibromyalgia Therapeutics
1.2 Classification of Fibromyalgia Therapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Fibromyalgia Therapeutics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Fibromyalgia Therapeutics (2011-2021)
  1.4.1 United States Fibromyalgia Therapeutics Sales and Growth Rate (2011-2021)
  1.4.2 United States Fibromyalgia Therapeutics Revenue and Growth Rate (2011-2021)

2 UNITED STATES FIBROMYALGIA THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Fibromyalgia Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Fibromyalgia Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Fibromyalgia Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Fibromyalgia Therapeutics Market Competitive Situation and Trends
  2.4.1 Fibromyalgia Therapeutics Market Concentration Rate
  2.4.2 Fibromyalgia Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES FIBROMYALGIA THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Fibromyalgia Therapeutics Sales and Market Share by Type (2011-2016)
3.2 United States Fibromyalgia Therapeutics Revenue and Market Share by Type (2011-2016)
3.3 United States Fibromyalgia Therapeutics Price by Type (2011-2016)
3.4 United States Fibromyalgia Therapeutics Sales Growth Rate by Type (2011-2016)

4 UNITED STATES FIBROMYALGIA THERAPEUTICS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Fibromyalgia Therapeutics Sales and Market Share by Application (2011-2016)
4.2 United States Fibromyalgia Therapeutics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES FIBROMYALGIA THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

5.1 Boehringer Ingelheim GmbH (Germany)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Boehringer Ingelheim GmbH (Germany) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Chelsea Therapeutics, Inc. (US)
  5.2.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Chelsea Therapeutics, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Claire Ellen Products, Inc. (US)
  5.3.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Claire Ellen Products, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly and Company (US)
  5.4.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly and Company (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Forest Laboratories, Inc. (US)
  5.5.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Forest Laboratories, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Impax Laboratories, Inc. (US)
  5.6.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Impax Laboratories, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Meda AB (Sweden)
  5.7.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Meda AB (Sweden) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Pfizer, Inc. (US)
  5.8.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Pfizer, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Pierre Fabre Medicament (France)
  5.9.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Pierre Fabre Medicament (France) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 FIBROMYALGIA THERAPEUTICS MANUFACTURING COST ANALYSIS

6.1 Fibromyalgia Therapeutics Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Fibromyalgia Therapeutics

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Fibromyalgia Therapeutics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Fibromyalgia Therapeutics Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES FIBROMYALGIA THERAPEUTICS MARKET FORECAST (2016-2021)

10.1 United States Fibromyalgia Therapeutics Sales, Revenue Forecast (2016-2021)
10.2 United States Fibromyalgia Therapeutics Sales Forecast by Type (2016-2021)
10.3 United States Fibromyalgia Therapeutics Sales Forecast by Application (2016-2021)
10.4 Fibromyalgia Therapeutics Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Fibromyalgia Therapeutics
Table Classification of Fibromyalgia Therapeutics
Figure United States Sales Market Share of Fibromyalgia Therapeutics by Type in 2015
Table Application of Fibromyalgia Therapeutics
Figure United States Sales Market Share of Fibromyalgia Therapeutics by Application in 2015
Figure United States Fibromyalgia Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Fibromyalgia Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Fibromyalgia Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Fibromyalgia Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Fibromyalgia Therapeutics Sales Share by Manufacturers
Figure 2016 Fibromyalgia Therapeutics Sales Share by Manufacturers
Table United States Fibromyalgia Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Fibromyalgia Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Fibromyalgia Therapeutics Revenue Share by Manufacturers
Table 2016 United States Fibromyalgia Therapeutics Revenue Share by Manufacturers
Table United States Market Fibromyalgia Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Fibromyalgia Therapeutics Average Price of Key Manufacturers in 2015
Figure Fibromyalgia Therapeutics Market Share of Top 3 Manufacturers
Figure Fibromyalgia Therapeutics Market Share of Top 5 Manufacturers
Table United States Fibromyalgia Therapeutics Sales by Type (2011-2016)
Table United States Fibromyalgia Therapeutics Sales Share by Type (2011-2016)
Figure United States Fibromyalgia Therapeutics Sales Market Share by Type in 2015
Table United States Fibromyalgia Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Fibromyalgia Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Fibromyalgia Therapeutics by Type (2011-2016)
Table United States Fibromyalgia Therapeutics Price by Type (2011-2016)
Figure United States Fibromyalgia Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Fibromyalgia Therapeutics Sales by Application (2011-2016)
Table United States Fibromyalgia Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Fibromyalgia Therapeutics Sales Market Share by Application in 2015
Table United States Fibromyalgia Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Fibromyalgia Therapeutics Sales Growth Rate by Application (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH (Germany) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Chelsea Therapeutics, Inc. (US) Basic Information List
Table Chelsea Therapeutics, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chelsea Therapeutics, Inc. (US) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Claire Ellen Products, Inc. (US) Basic Information List
Table Claire Ellen Products, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Claire Ellen Products, Inc. (US) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Forest Laboratories, Inc. (US) Basic Information List
Table Forest Laboratories, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Forest Laboratories, Inc. (US) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Impax Laboratories, Inc. (US) Basic Information List
Table Impax Laboratories, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Impax Laboratories, Inc. (US) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Meda AB (Sweden) Basic Information List
Table Meda AB (Sweden) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meda AB (Sweden) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer, Inc. (US) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Pierre Fabre Medicament (France) Basic Information List
Table Pierre Fabre Medicament (France) Fibromyalgia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pierre Fabre Medicament (France) Fibromyalgia Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fibromyalgia Therapeutics
Figure Manufacturing Process Analysis of Fibromyalgia Therapeutics
Figure Fibromyalgia Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Fibromyalgia Therapeutics Major Manufacturers in 2015
Table Major Buyers of Fibromyalgia Therapeutics
Table Distributors/Traders List
Figure United States Fibromyalgia Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Fibromyalgia Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Fibromyalgia Therapeutics Production Forecast by Type (2016-2021)
Table United States Fibromyalgia Therapeutics Consumption Forecast by Application (2016-2021)